CG MedTech Co.,Ltd. (KOSDAQ:056090)
1,517.00
+42.00 (2.85%)
At close: Jan 29, 2026
CG MedTech Revenue
CG MedTech had revenue of 11.35B KRW in the quarter ending September 30, 2025, with 33.62% growth. This brings the company's revenue in the last twelve months to 45.59B, up 28.83% year-over-year. In the year 2024, CG MedTech had annual revenue of 34.62B, down -0.99%.
Revenue (ttm)
45.59B
Revenue Growth
+28.83%
P/S Ratio
3.62
Revenue / Employee
379.93M
Employees
120
Market Cap
165.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.62B | -345.79M | -0.99% |
| Dec 31, 2023 | 34.97B | -6.20B | -15.06% |
| Dec 31, 2022 | 41.17B | 3.11B | 8.18% |
| Dec 31, 2021 | 38.06B | 10.28B | 37.01% |
| Dec 31, 2020 | 27.78B | -7.04B | -20.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 133.05B |
| JW Shinyak | 76.02B |
| Sewoon Medical | 62.13B |
| OSTEONIC | 42.11B |
| DuChemBIO | 37.25B |
| Wonbiogen | 34.38B |
| T&R Biofab | 20.67B |
| SCL Science | 16.32B |